NSRX NASUS PHARMA LTD
FollowORD SHS (common), issuer CIK 2029039
Filings received so far for Q3 2026: 9 13F filers report a position in NSRX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Balyasny Asset Management L.P.(group Balyasny Asset Management)
1,170,209 shares, 9.99% in a 13G/A as of 2026-09-30,0001172661-26-005053
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Balyasny Asset Management L.P.in group Balyasny Asset Management | 898,473 | $3.32M | 0.01% | 0 | 13F-HRTimelineGroup |
| Cable Car Capital, LP | 616,081 | $2.27M | 0.66% | 0 | 13F-HRTimeline |
| Velan Capital Investment Management LP | 359,390 | $1.33M | 1.27% | 0 | 13F-HRTimeline |
| Hudson Bay Capital Management LPin group Hudson Bay Capital Management… | 134,771 | $497K | <0.01% | 0 | 13F-HRTimelineGroup |
| Bleichroeder LPin group Bleichroeder LP | 89,848 | $332K | 0.03% | 0 | 13F-HRTimelineGroup |
| RENAISSANCE TECHNOLOGIES LLCin group RENAISSANCE TECHNOLOGIES LLC | 14,600 | $53.9K | <0.01% | +2,400 | 13F-HRTimelineGroup |
| Pinnacle Financial Group, Inc. | 9,712 | $35.8K | <0.01% | 13F-HRTimeline | |
| MORGAN STANLEYin group MORGAN STANLEY | 1,000 | $3.69K | <0.01% | 0 | 13F-HRTimelineGroup |
| Caitong International Asset Management … | 4 | $15 | <0.01% | 0 | 13F-HRTimeline |
Events
Balyasny Asset Management L.P. and 4 other reporting persons reported 1,170,209 NSRX shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001172661-26-005053
Accepted , ingested